Salivary Gland Acinic Cell Carcinoma — Trials

Salivary Gland Acinic Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00095563	Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers	completed	Phase 2	40	National Cancer Institute (NCI)NIH	1	Apr 18, 2017	clinicaltrials
NCT00126607	Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer	terminated	Phase 2	35	National Cancer Institute (NCI)NIH	1	Feb 28, 2013	clinicaltrials